MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jir.s576383

Медицинская библиотека · Journal of inflammation research · 2026

Evaluating Baricitinib for Severe Paediatric Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Single-Cell Sequencing.

Yang Danyang, Liu Xin, Jing Wenwen, Feng Xu, Lai Canying, Liu Chenyue, Xu Zhigang, Zhang Yangang, Han Jiayi, Geng Songmei, Li Ruilian, Li Dan, Cheng Boyi, Wu Yufei, Liu Zhuokun, Lian Jialin, Wang Zhenghui, Liu Yale, Li Xiaoli

СтатьяПеревод в очереди

Аннотация

PURPOSE: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe type of drug reaction that has significant mortality rate. Traditional treatments, including glucocorticoids and immunosuppressants, are sometimes insufficient. We present a case of severe paediatric DRESS unresponsive to conventional therapies, in which baricitinib, guided by single-cell RNA sequencing (scRNA-seq), led to clinical improvement. Single-cell transcriptomics is a revolutionary technology that allows scientists to measure the activity of all genes in individual cells on a large scale and has emerged as a tool for personalized therapeutic targeting.

PATIENT AND

METHODS

A 3-year-old male with DRESS triggered by phenobarbital presented with fever, skin rash, impaired liver function, eosinophilia, and cytomegalovirus infection. After failing high-dose corticosteroids, intravenous immunoglobulin, and etanercept, baricitinib was initiated. Peripheral blood mononuclear cells and skin biopsy samples underwent scRNA-seq to identify dysregulated pathways and potential therapeutic targets.

RESULTS

Baricitinib treatment led to resolution of skin lesions, normalization of eosinophil counts and liver function, and successful tapering of corticosteroids. Single-cell RNA sequencing uncovered that clusters of CD4+ and CD8+ T cells contain JAK2.

CONCLUSION

Our findings suggest that baricitinib, a JAK1/2 inhibitor, is a safe and effective salvage therapy for corticosteroid-refractory paediatric DRESS. scRNA-seq can guide targeted treatment decisions in DRESS.

Для цитирования: Yang Danyang, Liu Xin, Jing Wenwen, Feng Xu, Lai Canying, Liu Chenyue, Xu Zhigang, Zhang Yangang, Han Jiayi, Geng Songmei, Li Ruilian, Li Dan, Cheng Boyi, Wu Yufei, Liu Zhuokun, Lian Jialin, Wang Zhenghui, Liu Yale, Li Xiaoli. Evaluating Baricitinib for Severe Paediatric Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Single-Cell Sequencing.. Journal of inflammation research. 2026. DOI: 10.2147/jir.s576383.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.